Skip to content

Business meeting to consider S.545, to prohibit certain uses of xylazine, H.R.2159, to direct the Attorney General of the United States to submit to the Congress a report on Federal criminal offenses, S.2934, to limit the availability of ci

5 recorded connections shown. Select a record, office or person to follow its source references.

Start with
and connect to

Browse all held record sources

Zoom to read. Drag to explore. Select a connection.

Business meeting to consider S.545, to prohibit certain uses of xylazine, H.R.2159, to direct the Attorney General of the United States to submit to the Congress a report on Federal criminal offenses, S.2934, to limit the availability of ci

Hearings · Date not recorded

Business meeting to consider S.545, to prohibit certain uses of xylazine, H.R.2159, to direct the Attorney General of the United States to submit to the Congress a report on Federal criminal offenses, S.2934, to limit the availability of ci: 5 outgoing connections shown. Point at anyone to see how they are linked.Showing bounded source connections. Dates come from the held records; missing relationships remain unknown.

The source record

The source did not record a date for this entry.

Jurisdiction code
US
Title
Business meeting to consider S.545, to prohibit certain uses of xylazine, H.R.2159, to direct the Attorney General of the United States to submit to the Congress a report on Federal criminal offenses, S.2934, to limit the availability of ci
Starts at
2026-03-26T14:15:00+00:00
Location
Hart Senate Office Building, 216
Status
scheduled
Agenda url
https://www.congress.gov/event/119th-Congress/senate-event/338096
Video url
https://www.congress.gov/event/119th-Congress/senate-event/338096
Meeting type
meeting